Alix Serves as an Adaptor That Allows Human Parainfluenza Virus Type 1 to Interact with the Host Cell ESCRT System

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Boonyaratanakornkit, Jim ^a   Schomacker, Henrick ^a   Collins, Peter ^a   Schmidt, Alexander ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; ESCRT PROTEIN; PROTEASOME; PROTEIN ALIX; PROTEIN BRO1; PROTEIN C; PROTEIN CHMP4B; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENDOSOME; HUMAN; HUMAN CELL; NONHUMAN; PARAINFLUENZA VIRUS 1; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

BINDING, COMPETITIVE; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; DNA PRIMERS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; PARAINFLUENZA VIRUS 1, HUMAN; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; VIRAL PROTEINS;

EID: 84875093669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059462     Document Type: Article

References (51)

1. Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, et al. (1988) Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. Virus Res 11: 1-15.
2. Forster J, Ihorst G, Rieger CH, Stephan V, Frank HD, et al. (2004) Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr 163: 709-716.
3. Reed G, Jewett PH, Thompson J, Tollefson S, Wright PF, (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 175: 807-813.
4. Hui DS, Woo J, Hui E, Foo A, Ip M, et al. (2008) Influenza-like illness in residential care homes: a study of the incidence, aetiological agents, natural history and health resource utilisation. Thorax 63: 690-697.
5. Gottlieb J, Schulz TF, Welte T, Fuehner T, Dierich M, et al. (2009) Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation 87: 1530-1537.
6. Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ, (2001) Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 20: 646-653.
7. Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyaratanakornkit J, et al. (2011) Progress in the development of human parainfluenza virus vaccines. Expert review of respiratory medicine 5: 515-526.
8. Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T, (2006) Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res 121: 23-32.
9. Van Cleve W, Amaro-Carambot E, Surman SR, Bekisz J, Collins PL, et al. (2006) Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352: 61-73.
10. Boonyaratanakornkit JB, Bartlett EJ, Amaro-Carambot E, Collins PL, Murphy BR, et al. (2009) The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection. J Virol 83: 1892-1910.
11. Bartlett EJ, Cruz AM, Esker J, Castano A, Schomacker H, et al. (2008) Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates. J Virol 82: 8965-8977.
12. Chambers R, Takimoto T, (2009) Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products. J Gen Virol 90: 1906-1915.
13. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. (2004) The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101: 17264-17269.
14. Boonyaratanakornkit J, Bartlett E, Schomacker H, Surman S, Akira S, et al. (2011) The C proteins of human parainfluenza virus type 1 limit double-stranded RNA accumulation that would otherwise trigger activation of MDA5 and protein kinase R. J Virol. 85: 1495-1506.
15. Garcin D, Marq JB, Iseni F, Martin S, Kolakofsky D, (2004) A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. Journal of virology 78: 8799-8811.
16. Gotoh B, Takeuchi K, Komatsu T, Yokoo J, (2003) The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. Journal of virology 77: 3360-3370.
17. Schomacker H, Hebner RM, Boonyaratanakornkit J, Surman S, Amaro-Carambot E, et al. (2012) The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining stat1 in perinuclear aggregates at the late endosome. PloS one 7: e28382.
18. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG, (2003) AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114: 689-699.
19. Lee HH, Elia N, Ghirlando R, Lippincott-Schwartz J, Hurley JH, (2008) Midbody targeting of the ESCRT machinery by a noncanonical coiled coil in CEP55. Science 322: 576-580.
20. Matsuo H, Chevallier J, Mayran N, Le Blanc I, Ferguson C, et al. (2004) Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 303: 531-534.
21. Fisher RD, Chung HY, Zhai Q, Robinson H, Sundquist WI, et al. (2007) Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128: 841-852.
22. Usami Y, Popov S, Gottlinger HG, (2007) Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. Journal of virology 81: 6614-6622.
23. Gosselin-Grenet AS, Marq JB, Abrami L, Garcin D, Roux L, (2007) Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology 365: 101-112.
24. Irie T, Nagata N, Yoshida T, Sakaguchi T, (2008) Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles. Virology 371: 108-120.
25. Irie T, Shimazu Y, Yoshida T, Sakaguchi T, (2007) The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 81: 2263-2273.
26. Irie T, Inoue M, Sakaguchi T, (2010) Significance of the YLDL motif in the M protein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Virology 405: 334-341.
27. Kim J, Sitaraman S, Hierro A, Beach BM, Odorizzi G, et al. (2005) Structural basis for endosomal targeting by the Bro1 domain. Developmental cell 8: 937-947.
28. Bartlett EJ, Amaro-Carambot E, Surman SR, Collins PL, Murphy BR, et al. (2006) Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates. Vaccine 24: 2674-2684.
29. Bartlett EJ, Amaro-Carambot E, Surman SR, Newman JT, Collins PL, et al. (2005) Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys. Vaccine 23: 4631-4646.
30. Itoh M, Isegawa Y, Hotta H, Homma M, (1997) Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol 78 (Pt 12): 3207-3215.
31. Newman JT, Riggs JM, Surman SR, McAuliffe JM, Mulaikal TA, et al. (2004) Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses. J Virol 78: 2017-2028.
32. Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO, (2007) An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. The Journal of biological chemistry 282: 3847-3855.
33. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
34. Lim KL, Chew KC, Tan JM, Wang C, Chung KK, et al. (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. The Journal of neuroscience: the official journal of the Society for Neuroscience 25: 2002-2009.
35. Katoh K, Shibata H, Suzuki H, Nara A, Ishidoh K, et al. (2003) The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting. The Journal of biological chemistry 278: 39104-39113.
36. Crinelli R, Bianchi M, Menotta M, Carloni E, Giacomini E, et al. (2008) Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells. Molecular and cellular biochemistry 318: 129-145.
37. Katoh K, Shibata H, Hatta K, Maki M, (2004) CHMP4b is a major binding partner of the ALG-2-interacting protein Alix among the three CHMP4 isoforms. Archives of biochemistry and biophysics 421: 159-165.
38. Wollert T, Hurley JH, (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464: 864-869.
39. Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, et al. (2005) AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. Journal of virology 79: 8933-8941.
40. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. (2000) Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
41. Huang F, Kirkpatrick D, Jiang X, Gygi S, Sorkin A, (2006) Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Molecular cell 21: 737-748.
42. Ren X, Hurley JH, (2010) VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo. The EMBO journal 29: 1045-1054.
43. Luhtala N, Odorizzi G, (2004) Bro1 coordinates deubiquitination in the multivesicular body pathway by recruiting Doa4 to endosomes. The Journal of cell biology 166: 717-729.
44. Babst M, Wendland B, Estepa EJ, Emr SD, (1998) The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. The EMBO journal 17: 2982-2993.
45. Ichioka F, Kobayashi R, Katoh K, Shibata H, Maki M, (2008) Brox, a novel farnesylated Bro1 domain-containing protein that associates with charged multivesicular body protein 4 (CHMP4). FEBS J 275: 682-692.
46. Popov S, Popova E, Inoue M, Gottlinger HG, (2009) Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production. Journal of virology 83: 7185-7193.
47. Ariumi Y, Kuroki M, Maki M, Ikeda M, Dansako H, et al. (2011) The ESCRT system is required for hepatitis C virus production. PloS one 6: e14517.
48. Grogan CC, Moyer SA, (2001) Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology 288: 96-108.
49. Liu W, Duden R, Phair RD, Lippincott-Schwartz J, (2005) ArfGAP1 dynamics and its role in COPI coat assembly on Golgi membranes of living cells. The Journal of cell biology 168: 1053-1063.
50. Presley JF, Ward TH, Pfeifer AC, Siggia ED, Phair RD, et al. (2002) Dissection of COPI and Arf1 dynamics in vivo and role in Golgi membrane transport. Nature 417: 187-193.
51. Pelchen-Matthews A, Kramer B, Marsh M, (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. The Journal of cell biology 162: 443-455.